Nyxoah SA (NYXH) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Nyxoah SA (NYXH) closed at USD 1.25 on 2026-10-14, a change of -75 % over the past year, with a market capitalization of USD 121.19M.

Nyxoah SA recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Nyxoah SA key figures

Previous close

USD 1.25 (2026-10-14)

1-year change

-75 %

Market cap

USD 121.19M

Enterprise value

USD 81.29M

P/E ratio (trailing)

-0.48

P/E ratio (forward)

-1.45

EPS (trailing)

-2.48

EPS (forward)

-0.82

PEG ratio

n/a

Price to book

1.28

Revenue growth

472.8 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.57

Employees

153

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Nyxoah SA

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Nyxoah SA and compare it with other stocks.